T2 Biosystems, Inc.·4

Aug 10, 11:00 AM ET

T2 Biosystems, Inc. 4

4 · T2 Biosystems, Inc. · Filed Aug 10, 2015

Insider Transaction Report

Form 4
Period: 2015-08-06
CASTONGUAY MAURICE L
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2015-08-06+146,000146,000 total
    Exercise: $14.04Exp: 2025-08-06Common Stock (146,000 underlying)
Footnotes (1)
  • [F1]25% of the total shares vest on 08/06/2016, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 08/06/2019.

Documents

1 file
  • 4
    a4.xmlPrimary

    4